There is no single “dementia test.” Dementia is diagnosed through a combination of cognitive screening, blood work, brain imaging, and functional assessments. The process typically starts with a short screening test in a doctor’s office, takes 3 to 30 minutes depending on the tool used, and may expand into a more comprehensive evaluation if results raise concerns.
Short Screening Tests Used in Doctor’s Offices
Most people encounter dementia testing for the first time as a brief cognitive screening during a regular medical visit. Three tools are used most commonly, and they each take a different approach.
The Mini-Cog is the fastest, taking about 3 minutes. It has two parts: you’re asked to remember three words, then draw a clock showing a specific time (usually 11:10). The clock drawing is scored on three points: one for drawing a circle, one for placing the correct numbers, and one for positioning the hands correctly. After the clock drawing, you’re asked to recall the three words. It’s a quick filter, not a deep assessment.
The Mini-Mental State Exam (MMSE) is scored out of 30 and covers orientation (knowing the date, where you are), memory, attention, and language. It’s been used for decades and remains common, though it has a notable limitation: its cutoff scores for detecting early cognitive changes are very high (around 28 or 29 out of 30), which means small declines can be hard to catch.
The Montreal Cognitive Assessment (MoCA) is also scored out of 30 but includes more challenging tasks involving reasoning, planning, and spatial skills. This makes it better at picking up early, subtle changes in thinking. A large study of over 16,000 participants found it detects dementia with 83% sensitivity and 82% specificity at a cutoff score of 21, and catches mild cognitive impairment with 77% sensitivity at a cutoff of 24. These are solid numbers for a 10-to-15-minute office test, though they also mean some cases will be missed.
A Test You Can Take at Home
The Self-Administered Gerocognitive Examination, known as SAGE, is a pen-and-paper test you can complete on your own without a clinician present. It takes about 13 minutes and covers orientation, language, calculations, memory, abstract thinking, reasoning, and spatial skills. Scores range from 0 to 22.
SAGE has been validated with strong accuracy for detecting mild cognitive impairment, correctly identifying impaired individuals 79% of the time while maintaining 95% specificity (meaning very few false alarms). In one study, when doctors used SAGE results alongside their usual evaluation, they documented new cognitive concerns six times as often as doctors who didn’t have the test. It also predicted progression from mild impairment to dementia at least six months earlier than the MMSE. Four interchangeable versions exist, so it can be repeated over time to track changes. You can find it through Ohio State University’s website.
SAGE is not a substitute for a professional evaluation, but it gives you something concrete to bring to your doctor if you’re worried about your own thinking or a family member’s.
What the Cognitive Screening Actually Measures
The formal diagnostic framework recognizes six cognitive domains that can be affected by dementia: complex attention, executive function (planning, organizing, flexible thinking), learning and memory, language, perceptual-motor skills (navigating space, recognizing objects), and social cognition (reading emotions and social cues). A diagnosis of dementia requires significant decline in at least one of these domains that interferes with everyday independence.
The short screening tests cover some but not all of these domains. If a screening raises concerns, a neuropsychologist may perform a full evaluation, which can range from under an hour to 6 to 8 hours of face-to-face testing depending on what questions need answers. These comprehensive batteries probe each domain in detail and produce a profile of strengths and weaknesses rather than a single pass/fail score.
Blood Tests and Biomarkers
Blood work serves two purposes in a dementia evaluation. The first is ruling out treatable conditions that can mimic dementia. Doctors typically order a complete blood count, metabolic panel, and thyroid function tests. Vitamin deficiencies, thyroid disorders, and certain infections can all cause cognitive symptoms that improve with treatment.
The second purpose is newer and more specific to Alzheimer’s disease. In 2025, the FDA cleared the first blood test designed to detect Alzheimer’s-related brain changes. The test measures two proteins in the blood and calculates their ratio, which correlates with the presence of amyloid plaques in the brain. In clinical studies, 91.7% of people with a positive result had confirmed amyloid plaques on brain imaging, and 97.3% of those with a negative result were truly negative. This test is approved for adults 55 and older who are already showing symptoms, and it reduces the need for more invasive procedures like spinal taps or expensive PET scans.
Brain Imaging
Brain scans are not always part of a dementia workup, but they’re used when doctors need to see structural or functional changes in the brain, or to rule out other causes like strokes, fluid buildup, or tumors.
CT scans and MRIs look at brain structure. Both can reveal brain atrophy, where the brain’s outer layer thins, the grooves on its surface widen, and the fluid-filled spaces in the center expand. MRIs are more sensitive and better at detecting subtle damage from small strokes. These structural changes don’t confirm a specific type of dementia on their own, but they help narrow the picture.
PET scans go further by measuring brain activity. They can detect changes in how the brain uses glucose, map blood flow, and identify abnormal protein deposits associated with Alzheimer’s. Functional MRI and SPECT scans also measure brain activity and blood flow patterns, though they’re used less routinely.
How Daily Functioning Factors In
Cognitive test scores alone don’t determine a dementia diagnosis. Doctors also assess how well a person manages everyday life, because the defining feature of dementia (as opposed to mild cognitive impairment) is that cognitive decline has started to interfere with independence.
This assessment looks at two tiers of daily activities. Basic activities include dressing, bathing, feeding yourself, using the toilet, and moving around independently. Instrumental activities are more complex: managing finances, preparing meals, taking medications correctly, using transportation, shopping, doing housework, and communicating by phone or mail. Difficulty with instrumental activities tends to appear first, often before basic self-care becomes a problem. Tools like the Lawton Instrumental ADL Scale track these abilities over time and are particularly useful for spotting gradual decline that might not be obvious from a single visit.
If you or a family member notices trouble with tasks like paying bills on time, following recipes that used to be routine, or keeping track of medications, these functional changes are worth mentioning to a doctor. They’re often more telling than a screening score in isolation.